The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Initial signals of efficacy in cholangiocarcinoma from a phase Ib trial of varlitinib in combination with doublet chemotherapy (cisplatin + 5-fluororacil or capecitabine).
 
Chih-Yi Hsieh
Employment - ASLAN Pharmaceuticals
Leadership - ASLAN Pharmaceuticals
Stock and Other Ownership Interests - ASLAN Pharmaceuticals
 
Ming-Shiang Wu
No Relationships to Disclose
 
Mark McHale
Employment - ASLAN Pharmaceuticals
Leadership - ASLAN Pharmaceuticals
Stock and Other Ownership Interests - ASLAN Pharmaceuticals
 
Bertil Lindmark
Employment - ASLAN Pharmaceuticals
Leadership - ASLAN Pharmaceuticals
Stock and Other Ownership Interests - ASLAN Pharmaceuticals
 
Lilian Chow
Employment - ASLAN Pharmaceuticals
Leadership - ASLAN Pharmaceuticals
Stock and Other Ownership Interests - ASLAN Pharmaceuticals
 
Yee Chao
No Relationships to Disclose